方法：选取2012-06/2013-06我院收治的玻璃体积血患者88例88眼，随机将患者分为观察组和对照组，每组44例44眼。对照组患者采用血栓通的临床药物治疗方案，而观察组患者则在此基础之上加用丹参注射液电离子导入的临床药物治疗方案，并分别对两组患者的临床治疗情况和视力恢复情况进行深入细致的比较和分析。

结果：观察组患者治愈率和总有效率分别为75%和95%，均显著高于对照组患者的59%和77%，差别均具有统计学意义(P<0.05)； 与对照组患者相比，观察组患者视力处于0.6～0.9之间的比率明显提高，而处于0.2以下的比率则显著降低，同时观察组患者的全血比黏度、血浆比黏度、红细胞压积、纤维蛋白原等相关指标均明显改善，差别均具有统计学意义(P<0.05)。

结论：丹参注射液电离子导入疗法对于玻璃体积血患者临床治疗效果的提升以及视力功能的改善均具有积极的促进作用。

METHODS: Eighty-eight vitreous hemorrhage patients(88 eyes)were selected from June 2012 to June 2013 in our hospital. The patients were divided into observation group and control group randomly, with 44 cases(44 eyes)in each group. The patients in control group were treated with xueshuantong clinical drug treatment. The patients in observation group were treated with danshen injection iontophoresis clinical drug treatment. The clinical treatment and visual recovery situations of the patients in two groups were compared and analyzed.

RESULTS: The cure rate and total effective rate of observation group were 75% and 95%. The cure rate and total effective rate of control group were 59% and 77%. There were statistically significant differences(P<0.05). Compared with control group, the rate of patients in observation group with visual acuity between 0.6 to 0.9 was improved significantly, rate of visual acuity less 0.2 was reduced significantly, and the whole blood viscosity, plasma viscosity, hematocrit and fibrinogen were improved significantly, there were statistical significance(P<0.05).

CONCLUSION: Danshen injection iontophoresis therapy has positive role in improving clinical outcomes and promoting visual function for patients with vitreous hemorrhage.